Paul Laviolette
Director at Pulse Biosciences
Boston, Massachusetts
Overview
Work Experience
Director
2024 - Current
Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Raised $233,340,002.00 from Virginia Catalyst.
Managing Partner & Chief Operating Officer
2008
SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Managing Partner
2020
Medtech Convergence Fund is the convergence of advanced materials science, component miniaturization, sensors and software.
Director
2022
Director
2022
Deerfield Catalyst is a premier medtech incubator founded to develop transformational medtech solutions.
Director
2020
Edwards Lifesciences is a provider of science of heart valves and hemodynamic monitoring.
Director
2019
Chairman
2017
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.
Raised $129,596,339.00 from SV Health Investors, Lumira Ventures, Aperture Venture Partners, Wanxiang America Healthcare Investments Group, OSF Ventures, Bioventures Investors, EQT Life Sciences, Skydeck and Seroba Life Sciences.
Chairman
2016
Director
2016
CSA Medical is a provider of innovative spray cryotherapy medical device solutions.
Raised $159,045,664.00 from Blue Heron Capital, Ascension Ventures, TVM Capital Life Science, SV Health Investors, Tara Butler, Yonjin Venture, First Analysis and Intersouth Partners.